Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Ashton currently holds 25,000 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Ashton has been a net seller of REPH stock. They have purchased $10.2K and sold $2.4M worth of shares.
William Ashton's most recent insider trade was on Mar 30, 2026, when they sold 25,000 shares at $0.00 per share.
William Ashton serves as Executive at Recro Pharma, Inc. (REPH). They have executed 50 insider transactions totaling $2.4M over their tenure at the company.
William Ashton holds the position of Executive at Recro Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
William Ashton has shown a selling trading pattern, with $10.2K in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by William Ashton was on Mar 11, 2015, when they sold $519.6K worth of SCMP shares. This transaction involved 30,000 shares at $17.32 per share.
William Ashton currently owns 25,000 shares of Recro Pharma, Inc. (REPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Ashton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Ashton has 50 Form 4 filings on record as an insider at Recro Pharma, Inc..
Set alerts for William Ashton and 40,000+ other insiders.